{"count": 5, "results": [{"_id": "15218321", "pmid": 15218321, "title": "Oxidative stress status in kidney tissue after losartan and atenolol treatment in experimental renal failure.", "journal": "Nephron Exp Nephrol", "authors": ["Pechter U", "Aunapuu M", "Riispere Z", "Vihalemm T", "Kullissaar T", "Zilmer K", "Zilmer M", "Ots M"], "date": "2004-01-01T00:00:00Z", "doi": "10.1159/000078404", "meta_date_publication": "2004", "meta_volume": "97", "meta_issue": "2", "meta_pages": "e33-7", "score": 50058.984, "text_hl": "The aim of our study was to evaluate the changes in oxidative stress parameters after 2 and 4 weeks of treatment with @GENE_REN @GENE_24715 @@@renin@@@-angiotensin system (RAS)-blocking agent @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@losartan@@@ and beta-blocking agent @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ in experimental @<m>DISEASE_Kidney_Failure_Chronic</m> @DISEASE_MESH:D007676 @@@chronic renal failure@@@ (@<m>DISEASE_Kidney_Failure_Chronic</m> @DISEASE_MESH:D007676 @@@CRF@@@). ", "citations": {"NLM": "Pechter U, Aunapuu M, Riispere Z, Vihalemm T, Kullissaar T, Zilmer K, Zilmer M, Ots M. Oxidative stress status in kidney tissue after losartan and atenolol treatment in experimental renal failure. Nephron Exp Nephrol. 2004;97(2):e33-7. PMID: 15218321", "BibTeX": "@article{15218321, title={Oxidative stress status in kidney tissue after losartan and atenolol treatment in experimental renal failure.}, author={Pechter U and Aunapuu M and Riispere Z and Vihalemm T and Kullissaar T and Zilmer K and Zilmer M and Ots M}, journal={Nephron Exp Nephrol}, volume={97}, number={2}, pages={e33-7}}"}}, {"_id": "9567598", "pmid": 9567598, "title": "Effect of antihypertensives on plasma potassium in end stage renal disease: a retrospective study.", "journal": "J Indian Med Assoc", "authors": ["Tripathi M", "Kaushik S", "Gaur A", "Kher V"], "date": "1997-10-01T00:00:00Z", "meta_date_publication": "1997 Oct", "meta_volume": "95", "meta_issue": "10", "meta_pages": "543-5, 547", "score": 50058.582, "text_hl": "In conclusion, @<m>DISEASE_Kidney_Failure_Chronic</m> @DISEASE_MESH:D007676 @@@ESRD@@@ @SPECIES_9606 @@@patients@@@ taking @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ or @CHEMICAL_Captopril @CHEMICAL_MESH:D002216 @@@captopril@@@ are needed to be frequently monitored for blood @CHEMICAL_Potassium @CHEMICAL_MESH:D011188 @@@potassium@@@ levels and it would be advisable to avoid these drugs to control @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ in @<m>DISEASE_Kidney_Failure_Chronic</m> @DISEASE_MESH:D007676 @@@ESRD@@@ @SPECIES_9606 @@@patients@@@, especially, when scheduled for renal transplantation.", "citations": {"NLM": "Tripathi M, Kaushik S, Gaur A, Kher V. Effect of antihypertensives on plasma potassium in end stage renal disease: a retrospective study. J Indian Med Assoc. 1997 Oct;95(10):543-5, 547. PMID: 9567598", "BibTeX": "@article{9567598, title={Effect of antihypertensives on plasma potassium in end stage renal disease: a retrospective study.}, author={Tripathi M and Kaushik S and Gaur A and Kher V}, journal={J Indian Med Assoc}, volume={95}, number={10}, pages={543-5, 547}}"}}, {"_id": "14578640", "pmid": 14578640, "title": "Ultrastructural changes in the remnant kidney (after 5/6 nephrectomy) glomerulus after losartan and atenolol treatment.", "journal": "Medicina (Kaunas)", "authors": ["Aunapuu M", "Pechter U", "Arend A", "Suuroja T", "Ots M"], "date": "2003-01-01T00:00:00Z", "meta_date_publication": "2003", "meta_volume": "39", "meta_issue": "10", "meta_pages": "975-9", "score": 50053.0, "text_hl": "The aim of our study was to investigate the effect of @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@losartan@@@ on the changes in the early stages (at week 4) of experimental @<m>DISEASE_Kidney_Failure_Chronic</m> @DISEASE_MESH:D007676 @@@chronic renal failure@@@ after 5/6 nephrectomy compared with the impact of @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@. ", "citations": {"NLM": "Aunapuu M, Pechter U, Arend A, Suuroja T, Ots M. Ultrastructural changes in the remnant kidney (after 5/6 nephrectomy) glomerulus after losartan and atenolol treatment. Medicina (Kaunas). 2003;39(10):975-9. PMID: 14578640", "BibTeX": "@article{14578640, title={Ultrastructural changes in the remnant kidney (after 5/6 nephrectomy) glomerulus after losartan and atenolol treatment.}, author={Aunapuu M and Pechter U and Arend A and Suuroja T and Ots M}, journal={Medicina (Kaunas)}, volume={39}, number={10}, pages={975-9}}"}}, {"_id": "15250920", "pmid": 15250920, "title": "Drug therapy for hypertension in hemodialysis patients.", "journal": "Semin Dial", "authors": ["Hörl MP", "Hörl WH"], "date": "2004-07-01T00:00:00Z", "doi": "10.1111/j.0894-0959.2004.17329.x", "meta_date_publication": "2004 Jul-Aug", "meta_volume": "17", "meta_issue": "4", "meta_pages": "288-94", "score": 50040.45, "text_hl": "@CHEMICAL_Lisinopril @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ and @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ have a predominant renal excretion and therefore a prolonged half life in @<m>DISEASE_Kidney_Failure_Chronic</m> @DISEASE_MESH:D007676 @@@ESRD@@@ @SPECIES_9606 @@@patients@@@. ", "citations": {"NLM": "Hörl MP, Hörl WH. Drug therapy for hypertension in hemodialysis patients. Semin Dial. 2004 Jul-Aug;17(4):288-94. PMID: 15250920", "BibTeX": "@article{15250920, title={Drug therapy for hypertension in hemodialysis patients.}, author={Hörl MP and Hörl WH}, journal={Semin Dial}, volume={17}, number={4}, pages={288-94}}"}}, {"_id": "23046209", "pmid": 23046209, "title": "Octreotide for the treatment of sulfonylurea poisoning.", "journal": "Clin Toxicol (Phila)", "authors": ["Glatstein M", "Scolnik D", "Bentur Y"], "date": "2012-11-01T00:00:00Z", "doi": "10.3109/15563650.2012.734626", "meta_date_publication": "2012 Nov", "meta_volume": "50", "meta_issue": "9", "meta_pages": "795-804", "score": 50019.074, "text_hl": "One adult @SPECIES_9606 @@@patient@@@ with @<m>DISEASE_Kidney_Failure_Chronic</m> @DISEASE_MESH:D007676 @@@chronic renal failure@@@ treated with @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ developed severe @DISEASE_Hyperkalemia @DISEASE_MESH:D006947 @@@hyperkalemia@@@. ", "citations": {"NLM": "Glatstein M, Scolnik D, Bentur Y. Octreotide for the treatment of sulfonylurea poisoning. Clin Toxicol (Phila). 2012 Nov;50(9):795-804. PMID: 23046209", "BibTeX": "@article{23046209, title={Octreotide for the treatment of sulfonylurea poisoning.}, author={Glatstein M and Scolnik D and Bentur Y}, journal={Clin Toxicol (Phila)}, volume={50}, number={9}, pages={795-804}}"}}]}